Battleground IBM: July 22 Earnings Will Settle Whether Clients’ AI Shift Is a Blip or a Break
Published on 07/20/2026 at 16:04 | Redaktion boerse-global.de
For a stock that had been a refuge of predictability, the scale of the damage is jarring. IBM shares cratered 25% on July 14 — the company’s worst single-day rout in nearly 40 years — after a preliminary second-quarter update revealed a revenue miss that shattered the narrative of a smooth AI-powered transformation. At Friday’s close of €185.72, the equity sits just 4% above its 52-week trough of €178.52 and a full 36.6% below June’s peak of €292.85. The 14-day relative strength index reading of 31.2 points to oversold conditions, but the annualized 30-day volatility of nearly 84% suggests calm is not yet in sight.
The source of the pain is a reordering of corporate budgets that caught Armonk off guard. Chief executive Arvind Krishna explained that clients began shifting spending en masse toward AI infrastructure — servers, storage and memory chips needed for training large language models — during the final weeks of the quarter. Software revenue still managed a 5% increase, but the infrastructure division slumped 7%, chaining the top-line result to $17.2 billion against the $17.86 billion analysts had penciled in. Adjusted earnings per share of $2.93 also missed the $3.01 consensus.
That discrepancy has now drawn the attention of plaintiffs’ lawyers. Several firms, including Bleichmar Fonti & Auld, are probing whether management misrepresented the health of the IBM Z mainframe pipeline before the warning. The potential securities-fraud claim centers on whether earlier guidance on the pace of mainframe sales was overly optimistic. Regulators have also opened an inquiry, though the process remains at an early stage.
In the wake of the miss, a divided analyst community has taken up positions on either side of a widening fault line. The 22 analysts covering the stock still maintain a “Moderate Buy” consensus, with a median price target near €258.80 — implying roughly 39% upside from current levels. Bank of America reaffirmed its buy rating while trimming its target, explicitly anticipating a downgrade to the full-year outlook, particularly in software. Evercore ISI, by contrast, doubled down with an “Outperform” vote of confidence. But HSBC has broken ranks, cutting its rating to “Reduce” and slashing its price objective to $191, arguing that IBM’s valuation is no longer justified relative to sector medians.
Should investors sell immediately? Or is it worth buying IBM?
The bulls point to bright spots that complicate a simple narrative of broad decay. Distributed infrastructure sales jumped 37% year on year, a record. Red Hat’s growth accelerated to 11%. And on July 15, IBM unveiled the Power S1112 server, powered by the new Power11 chip, with sales starting July 24. Yet the timing is awkward: the new hardware competes not with incremental performance gains but with the massive AI clusters that are now sucking up the bulk of enterprise IT budgets. Meanwhile, the mainframe business — historically a pillar of stability — is fading faster than expected as the previous z17 upgrade cycle runs its course. Management itself has acknowledged the decline in the Z and transaction processing segments.
All of this converges on a single point of uncertainty: the full quarterly report and investor conference scheduled for July 22. Until then, the stock remains suspended between two opposing scenarios.
The optimistic case rests on the idea that the customer budget reallocation is a temporary blip, not a structural shift. If Krishna can demonstrate that the large deals delayed in June closed in July and that the full-year guidance — still standing at more than 5% currency-adjusted revenue growth plus a $1 billion increase in free cash flow — remains intact, the oversold technicals could fuel a snapback rally. The 50-day moving average near €228.94 would then become the first realistic recovery target.
The bearish alternative is that the July 14 warning marks the beginning of a lasting revaluation. A lowered forecast, especially for software, would call into question all the growth assumptions underpinning IBM’s AI and mainframe ambitions. Should the investigation into pipeline disclosures produce adverse findings, the legal overhang would compound the operational drag. In that case, the nascent low near €178.52 would likely be retested or broken.
IBM at a turning point? This analysis reveals what investors need to know now.
Two facts underscore why the July 22 earnings call matters so much. First, the preliminary data were just that — preliminary, with books not yet closed — so the final numbers could still shift. Second, management deliberately withheld an updated outlook in the initial communication, leaving the $1 billion cash-flow target in limbo. The combination leaves room for both a cathartic relief rally and a deeper sell-off.
Investors thus face an unusually binary bet. The 30-day volatility near 84% — more typical of a growth stock than a long-established tech heavyweight — reflects a market that has priced in almost nothing except the possibility of radical change. On July 22, the company will finally have to show whether it can still navigate the tension between the legacy that made it and the AI-driven future that threatens to leave it behind.
Ad
IBM Stock: New Analysis - 20 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
